Transcriptional and functional consequences of alterations to MEF2C and its topological organization in neuronal models
暂无分享,去创建一个
S. Erdin | B. Menten | J. Gusella | M. Talkowski | Matthew H. Larson | Benjamin Currall | Philip M Boone | Kiana Mohajeri | M. Moyses-Oliveira | D. Tai | Chelsea Lowther | D. Lucente | S. Vergult | Dadi Gao | M. Salani | Eva D’haene | Kathryn O’Keefe | N. Burt | Rachita Yadav | Riya Bhavsar | Serkan Erdin | M. Moyses-Oliveira
[1] Ryan L. Collins,et al. Rare coding variation provides insight into the genetic architecture and phenotypic context of autism , 2022, Nature Genetics.
[2] Ryan L. Collins,et al. Rare coding variation illuminates the allelic architecture, risk genes, cellular expression patterns, and phenotypic context of autism , 2021, medRxiv.
[3] Jacob C. Ulirsch,et al. Direct characterization of cis-regulatory elements and functional dissection of complex genetic associations using HCR-FlowFISH , 2021, Nature Genetics.
[4] Evin M. Padhi,et al. Coding and noncoding variants in EBF3 are involved in HADDS and simplex autism , 2021, Human genomics.
[5] L. Pasquali,et al. UMI4Cats: an R package to analyze chromatin contact profiles obtained by UMI-4C , 2021, Bioinform..
[6] S. Mundlos,et al. Diagnostic Yield of Whole Genome Sequencing After Nondiagnostic Exome Sequencing or Gene Panel in Developmental and Epileptic Encephalopathies , 2021, Neurology.
[7] J. de Ridder,et al. svMIL: predicting the pathogenic effect of TAD boundary-disrupting somatic structural variants through multiple instance learning. , 2020, Bioinformatics.
[8] David R. Kelley,et al. Predicting 3D genome folding from DNA sequence with Akita , 2020, Nature Methods.
[9] E. Tsvetkov,et al. MEF2C Hypofunction in Neuronal and Neuroimmune Populations Produces MEF2C Haploinsufficiency Syndrome–like Behaviors in Mice , 2020, Biological Psychiatry.
[10] B. Menten,et al. A neuronal enhancer network upstream of MEF2C is compromised in patients with Rett like characteristics. , 2020, Human molecular genetics.
[11] Ryan L. Collins,et al. The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.
[12] B. Ng,et al. Disruption of chromatin organisation causes MEF2C gene overexpression in intellectual disability: a case report , 2019, BMC Medical Genomics.
[13] M. T. B. Geller,et al. Molecular , 2019, Modern Pathology.
[14] S. Mundlos,et al. Functional dissection of the Sox9–Kcnj2 locus identifies nonessential and instructive roles of TAD architecture , 2019, Nature Genetics.
[15] Hagen U. Tilgner,et al. SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse , 2019, Neuron.
[16] E. Furlong,et al. Highly rearranged chromosomes reveal uncoupling between genome topology and gene expression , 2019, Nature Genetics.
[17] Miguel A. Soler,et al. AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders , 2019, Nature Communications.
[18] D. Goldstein,et al. Noncoding Deletions Expose a Novel Gene Critical for Intestinal Function , 2019, Nature.
[19] J. Baptista,et al. Modeling the Pathological Long-Range Regulatory Effects of Human Structural Variation with Patient-Specific hiPSCs. , 2019, Cell stem cell.
[20] S. Weiss,et al. MEF2C-related epilepsy: Delineating the phenotypic spectrum from a novel mutation and literature review , 2019, Seizure.
[21] R. Touraine,et al. Whole genome paired-end sequencing elucidates functional and phenotypic consequences of balanced chromosomal rearrangement in patients with developmental disorders , 2019, Journal of Medical Genetics.
[22] Fereydoun Hormozdiari,et al. TAD fusion score: discovery and ranking the contribution of deletions to genome structure , 2019, Genome Biology.
[23] Ilya M. Flyamer,et al. Developmentally regulated Shh expression is robust to TAD perturbations , 2019, Development.
[24] B. Black,et al. Cardiovascular development and survival require Mef2c function in the myocardial but not the endothelial lineage. , 2019, Developmental biology.
[25] Jan Gorodkin,et al. Cytoscape stringApp: Network analysis and visualization of proteomics data , 2018, bioRxiv.
[26] Stephan J Sanders,et al. Integrative functional genomic analysis of human brain development and neuropsychiatric risks , 2018, Science.
[27] Ryan L. Collins,et al. Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder , 2018, Science.
[28] X. Bao,et al. Novel MEF2C point mutations in Chinese patients with Rett (−like) syndrome or non-syndromic intellectual disability: insights into genotype-phenotype correlation , 2018, BMC medical genetics.
[29] Ryan L. Collins,et al. An analytical framework for whole-genome sequence association studies and its implications for autism spectrum disorder , 2018, Nature Genetics.
[30] Ryan L. Collins,et al. Dissecting the Causal Mechanism of X-Linked Dystonia-Parkinsonism by Integrating Genome and Transcriptome Assembly , 2018, Cell.
[31] Judith B. Zaugg,et al. CTCF-Mediated Chromatin Loops between Promoter and Gene Body Regulate Alternative Splicing across Individuals. , 2017, Cell systems.
[32] Sören Müller,et al. Single-cell Co-expression Subnetwork Analysis , 2017, Scientific Reports.
[33] François Dubeau,et al. High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies. , 2017, American journal of human genetics.
[34] Erez Lieberman Aiden,et al. Cohesin Loss Eliminates All Loop Domains , 2017, Cell.
[35] Nuno A. Fonseca,et al. Two independent modes of chromatin organization revealed by cohesin removal , 2017, Nature.
[36] E. Olson,et al. Notch Inhibition Enhances Cardiac Reprogramming by Increasing MEF2C Transcriptional Activity , 2017, Stem cell reports.
[37] Edwin Cuppen,et al. The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies , 2016, Nature Genetics.
[38] Damian Szklarczyk,et al. The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible , 2016, Nucleic Acids Res..
[39] S. Mundlos,et al. Formation of new chromatin domains determines pathogenicity of genomic duplications , 2016, Nature.
[40] Genevieve Konopka,et al. MEF2C regulates cortical inhibitory and excitatory synapses and behaviors relevant to neurodevelopmental disorders , 2016, eLife.
[41] R. Rocha,et al. MEF2C haploinsufficiency syndrome: Report of a new MEF2C mutation and review. , 2016, European journal of medical genetics.
[42] R. Schiestl,et al. MEF2C protects bone marrow B-lymphoid progenitors during stress haematopoiesis , 2016, Nature Communications.
[43] Pedro Olivares-Chauvet,et al. UMI-4C for quantitative and targeted chromosomal contact profiling , 2016, Nature Methods.
[44] A. Righini,et al. Prenatal detection of 5q14.3 duplication including MEF2C and brain phenotype , 2016, American journal of medical genetics. Part A.
[45] J. Mesirov,et al. The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .
[46] A. Visel,et al. Disruptions of Topological Chromatin Domains Cause Pathogenic Rewiring of Gene-Enhancer Interactions , 2015, Cell.
[47] I. Rigoutsos,et al. “Off-Spotter”: very fast and exhaustive enumeration of genomic lookalikes for designing CRISPR/Cas guide RNAs , 2015, Biology Direct.
[48] Howard Y. Chang,et al. ATAC‐seq: A Method for Assaying Chromatin Accessibility Genome‐Wide , 2015, Current protocols in molecular biology.
[49] Tomas W. Fitzgerald,et al. Large-scale discovery of novel genetic causes of developmental disorders , 2014, Nature.
[50] Neva C. Durand,et al. A 3D Map of the Human Genome at Kilobase Resolution Reveals Principles of Chromatin Looping , 2014, Cell.
[51] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[52] Kali T. Witherspoon,et al. Refining analyses of copy number variation identifies specific genes associated with developmental delay , 2014, Nature Genetics.
[53] J. Leek. svaseq: removing batch effects and other unwanted noise from sequencing data , 2014, bioRxiv.
[54] Edwin Cuppen,et al. Mate pair sequencing for the detection of chromosomal aberrations in patients with intellectual disability and congenital malformations , 2013, European Journal of Human Genetics.
[55] S. Horvath,et al. Integrative Functional Genomic Analyses Implicate Specific Molecular Pathways and Circuits in Autism , 2013, Cell.
[56] U. Stephani,et al. Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes , 2013, Nature Genetics.
[57] Eli J. Fine,et al. DNA targeting specificity of RNA-guided Cas9 nucleases , 2013, Nature Biotechnology.
[58] T. Südhof,et al. Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells , 2013, Neuron.
[59] S. Esposito,et al. MEF2C deletions and mutations versus duplications: a clinical comparison. , 2013, European journal of medical genetics.
[60] Marni J. Falk,et al. MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathways , 2013, neurogenetics.
[61] V. Vedantham,et al. Spatiotemporal regulation of an Hcn4 enhancer defines a role for Mef2c and HDACs in cardiac electrical patterning. , 2013, Developmental biology.
[62] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[63] H. Mikkola,et al. Mef2C Maintains B Cell Homeostasis Through the Regulation of DNA Repair Machinery , 2012 .
[64] Gary D Bader,et al. A travel guide to Cytoscape plugins , 2012, Nature Methods.
[65] J. Chelly,et al. Refining the phenotype associated with MEF2C point mutations , 2012, neurogenetics.
[66] Data production leads,et al. An integrated encyclopedia of DNA elements in the human genome , 2012 .
[67] B. Porter,et al. MEF2C haploinsufficiency syndrome: A severe neurodevelopmental disorder with variable epilepsy , 2012, Journal of Pediatric Epilepsy.
[68] H. Mori,et al. De novo microdeletion of 5q14.3 excluding MEF2C in a patient with infantile spasms, microcephaly, and agenesis of the corpus callosum , 2012, American journal of medical genetics. Part A.
[69] H. Kurahashi,et al. Clinical spectrum of SCN2A mutations , 2012, Brain and Development.
[70] ENCODEConsortium,et al. An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.
[71] Chris Williams,et al. RNA-SeQC: RNA-seq metrics for quality control and process optimization , 2012, Bioinform..
[72] Jesse R. Dixon,et al. Topological Domains in Mammalian Genomes Identified by Analysis of Chromatin Interactions , 2012, Nature.
[73] Evan T. Geller,et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.
[74] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[75] N. Miyake,et al. De novo 5q14.3 translocation 121.5‐kb upstream of MEF2C in a patient with severe intellectual disability and early‐onset epileptic encephalopathy , 2011, American journal of medical genetics. Part A.
[76] Peter J. Bickel,et al. Measuring reproducibility of high-throughput experiments , 2011, 1110.4705.
[77] M. Vikkula,et al. 5q14.3 neurocutaneous syndrome: A novel continguous gene syndrome caused by simultaneous deletion of RASA1 and MEF2C , 2011, American journal of medical genetics. Part A.
[78] Golder N Wilson,et al. Interstitial deletion 5q14.3q21.3 with MEF2C haploinsufficiency and mild phenotype: When more is less , 2011, American journal of medical genetics. Part A.
[79] Helga Thorvaldsdóttir,et al. Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..
[80] C. Martin,et al. 5 q 14 . 3 Neurocutaneous Syndrome : A Novel Continguous Gene Syndrome Caused by Simultaneous Deletion of RASA 1 and MEF 2 C , 2011 .
[81] E. Ortibus,et al. Refining the phenotype associated with MEF2C haploinsufficiency , 2010, Clinical genetics.
[82] P. Stankiewicz,et al. Severe mental retardation, seizures, and hypotonia due to deletions of MEF2C , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[83] T. Vuocolo,et al. A gene network switch enhances the oxidative capacity of ovine skeletal muscle during late fetal development , 2010, BMC Genomics.
[84] H. Firth,et al. Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression , 2010, Human mutation.
[85] M. Venere,et al. The Rho Guanine Nucleotide Exchange Factor AKAP13 (BRX) Is Essential for Cardiac Development in Mice* , 2010, The Journal of Biological Chemistry.
[86] H. Firth,et al. Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression , 2010, Human mutation.
[87] I. Amit,et al. Comprehensive mapping of long range interactions reveals folding principles of the human genome , 2011 .
[88] S. Auvin,et al. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations , 2009, Journal of Medical Genetics.
[89] Dagmar Wieczorek,et al. A novel microdeletion syndrome involving 5q14.3-q15: clinical and molecular cytogenetic characterization of three patients , 2009, European Journal of Human Genetics.
[90] Manuel Corpas,et al. DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. , 2009, American journal of human genetics.
[91] I. Scheffer,et al. Periventricular heterotopia, mental retardation, and epilepsy associated with 5q14.3-q15 deletion , 2009, Neurology.
[92] Steve Horvath,et al. WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.
[93] Clifford A. Meyer,et al. Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.
[94] Mi-Sung Kim,et al. MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function , 2008, Proceedings of the National Academy of Sciences.
[95] Jiankun Cui,et al. Myocyte Enhancer Factor 2C as a Neurogenic and Antiapoptotic Transcription Factor in Murine Embryonic Stem Cells , 2008, The Journal of Neuroscience.
[96] A. Cao,et al. Two patients with balanced translocations and autistic disorder: CSMD3 as a candidate gene for autism found in their common 8q23 breakpoint area , 2008, European Journal of Human Genetics.
[97] Michael L. Creech,et al. Integration of biological networks and gene expression data using Cytoscape , 2007, Nature Protocols.
[98] Steven W. Flavell,et al. Activity-Dependent Regulation of MEF2 Transcription Factors Suppresses Excitatory Synapse Number , 2006, Science.
[99] Terrence S. Furey,et al. The UCSC Genome Browser Database: update 2006 , 2005, Nucleic Acids Res..
[100] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[101] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[102] M. Gómez-Ferrería,et al. Functional domains of FOXJ2. , 2003, Journal of molecular biology.
[103] C. Bucana,et al. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. , 1997, Science.